Mission Hospital
About Us My Mission News Room Careers Contact Us
Find Services at Mission Hospital Our Doctors Our Services For Patients For Visitors For Community
Health Library
Health News
Health Encyclopedia
Healthy Recipes
Tests & Procedures
Cardiovascular
Gastroenterology
Gynecology
Neurological
Orthopaedic
Pulmonary
Urology
Health Tools
Calculators
Quizzes
Risk Assessments
Wellness Library
At Work
Behavior
Dental
Diseases & Conditions
Fitness
Injuries & Emergencies
Nutrition
Parenting
Prevention
Safety
Today's Medicine
Weight Control
Your Body

Share this page:

Facebook
Twitter
Google +

Scientists Focus on Factors Behind Asthma Attacks

THURSDAY, Sept. 20 (HealthDay News) -- Blocking two particular biological processes might help provide relief to people with asthma, according to a new study.

The University of California, San Francisco-led team found that a specific calcium-activated chloride channel called TMEM16A plays a role in the severity of asthma. The channel regulates airway secretions and smooth-muscle contraction: the major factors that lead to an asthma attack.

"Maybe if we could inhibit both of these processes by blocking this one channel, then we could affect the two symptoms of asthma," study senior author Jason Rock, an assistant professor at the UCSF anatomy department, said in a university news release.

People with asthma have a higher-than-normal number of mucus-producing cells in the lining of the airway tubes that lead to the lungs, and they also have an abnormal amount of smooth muscle surrounding the airway tubes. The slightest stimulus can cause the tubes to contract.

"The overabundance of mucus plugging the airways combined with hyper-contractility of the smooth muscle -- when the tubes get really small -- make it difficult to move air in or out," Rock explained. "A lot of people equate that with breathing through a straw."

In laboratory tests, the researchers identified three chemicals that inhibited the activity of TMEM16A and led to reduced mucus production and smooth muscle contraction.

The study was published Sept. 17 in the journal Proceedings of the National Academy of Sciences.

The next step is to test the safety and effectiveness of these chemical blockers in animals, the researchers say. If that goes well, human clinical trials could follow.

More information

The U.S. National Heart, Lung, and Blood Institute has more about asthma.

SOURCE: University of California, San Francisco, news release, Sept. 14, 2012